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Objective: Deep brain stimulation (DBS) has promising outcomes in
treatment-resistant depression (TRD). Several regions, including the
subcallosal cingulate gyrus (SCG), nucleus accumbens, ventral capsule/
ventral striatum, and lateral habenula (LHb), can be targeted for TRD
treatment. However, which target provides the best results remains
controversial.
Methods: We evaluated the antidepressant and antianxiety effects of
DBS of the ventral medial prefrontal cortex (vmPFC) and LHb in stressed
rats using the forced swimming test (FST) and open field test (OFT).
Results: Bilateral high-frequency DBS of the vmPFC and LHb induced
a significant decrease of the immobility time compared with that of
controls (p < 0.05) in the FST. In the OFT, rats receiving vmPFC and LHb
DBS showed no difference in the number of entries and time spent in the
center area compared with those of control rats. However, vmPFC DBS
provoked a significant decrease of these parameters compared with those
of rats receiving LHb DBS (p < 0.05).
Conclusion: These results suggested that vmPFC and LHb DBS had
similar antidepressant effects, whereas LHb DBS was more effective in
reducing anxiety-like behaviors. The results provide a reference for
high-frequency DSB of SCG and LHb in TRD.

© The authors 2022. This article
is published with open access at
www.sciopen.com/journal/2324-2426,
distributed under the terms of Creative
Commons Attribution 4.0 International
License (CC BY).
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Introduction

Deep brain stimulation (DBS) has shown promising
outcomes in treatment-resistant depression (TRD)
[1, 2]. Clinical studies have identified the lateral
habenula (LHb) and subcallosal cingulate gyrus

(SCG) as putative therapeutic brain targets of
DBS in TRD [3–8]. However, the better target for
DBS use in TRD patients remains controversial.
Investigating the effects and the therapeutic neural
mechanisms of DBS of homologous regions in
animals might contribute to clarify this issue [9, 10].
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The LHb is a phylogenetically old structure
located in the dorsomedial portion of the thalamus
and is highly homologous between rodents and
humans [11, 12]. The ventral medial prefrontal
cortex (vmPFC), particularly the infralimbic cortex,
is the region in rodents corresponding to the
SCG of humans [13, 14]. Previous studies have
suggested that high-frequency DBS of vmPFC
and LHb has a potential antidepressant effects
in humans and animals [3, 6, 15, 16]. Anxiety is
a common comorbidity diagnosed at a rate as
high as 75% in patients with depression [17, 18].
Although no specific adverse effects were observed
in a randomized, controlled trial of SCG DBS in
TRD, a minority of patients presented increased
anxiety levels [6]. Additionally, only a few patients
with TRD received LHb DBS so far and its effect
on anxiety remains unclear [4, 7, 8].
Here, we investigated the antidepressant effects
of vmPFC and LHb DBS in the forced swim test

Committee of Peking University Health Science
Center (Approval No. LA2017131).
2.2

Surgical procedures

Rats were anesthetized with 40 mg/kg sodium
pentobarbital and then were secured in a
stereotaxic apparatus. The electrodes were
implanted into either the vmPFC (anteroposterior
3.0 mm from bregma, mediolateral 0.4 mm,
and dorsoventral −4.6 mm from dura) or the
LHb (anteroposterior −3.7 mm from bregma,
mediolateral 0.7 mm, and dorsoventral −5.4 mm
from dura). Monopolar stainless-steel electrodes
(125 μm in diameter and 0.5 mm of exposed
surface) were used as cathodes. Similar electrodes
were secured to the bone screw in the skull as
anodes. Identical electrodes were implanted in
control animals but the stimulation was turned
off. After surgery, rats were housed individually
to recover for 7 days. Then, behavioral experiments
were conducted.

(FST). Moreover, anxiety, which is an important
aspect of depressive-type states in rodents, was

2.3

assessed using the open field test (OFT).

Stimulation was applied using a handheld device
(PINS Medical model T902, Beijing, China) at
150 μA, 130 Hz, and 90 μs [19, 20]. The stimulation
time frame was selected based on previous
work [20].
On the first day, rats were individually placed
in a cylinder (20 cm diameter, 80 cm tall) filled
with water at 25 ± 1°C and a depth of 40 cm for
15 min. On the second day, DBS-treated animals
received continuous DBS for 4 h and then were
subjected to FST for 5 min. The time spend
by the animals exhibiting specific behaviors
(immobility, swimming, or climbing) during the
last 4 min of the test was blindly calculated [21].
In the FST, low immobility time is associated
with an antidepressant effect.

2 Methods
2.1

Animals

A total of 34 male Sprague–Dawley rats (Animal
Center of Peking University, China) weighing
250–300 g at the start of experiments were used.
Rats were habituated to the environment for
7 days and maintained on a 12:12-h light–dark
cycle (lights off at 6:30 a.m.). The room temperature was controlled at 22 ± 3 °C, and the
relative humidity was 60% ± 15%. Food and water
were available ad libitum. All experiments met
the requirements of the National Institute of
Health Guide for the Care and Use of Laboratory
Animals (National Research Council 1996), and
the procedures were approved by the Animal Use

2.4

Electrical stimulation and FST

OFT

On the third day, rats underwent 1 h of stimulation
Journal of Neurorestoratology

Journal of Neurorestoratology

followed by a 7-min OFT, which was performed
in a squared 100 cm × 100 cm × 50 cm box
(Shanghai Mobiledatum Information Technology
Co., Shanghai, China). Time spent (C-Time) and
numbers of entries (C-Dis) in the central area
(60 cm × 60 cm) and total distance traveled (T-Dis)
in the field were measured using the SMART
software (version 2.5.21, Panlab, SMART Video
tracking, Boston, USA). The box was cleaned with
75% ethanol between tests.
2.5

Histology

The correct placement of DBS electrodes in the
vmPFC and LHb was verified for all rats after
completion of the experiments. All DBS tips
were mapped onto standardized sections of the
rat brain (shown in Fig. 1). Two rats were excluded
from the analysis because of incorrect electrode
placement in the vmPFC. Therefore, 12 rats
receiving LHb DBS and 10 rats receiving vmPFC
DBS were analyzed.
2.6

Statistical analysis

All data were presented as means ± standard
errors. FST and OFT data (shown in Figs. 2 and 3)
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were analyzed by one-way ANOVA and Bartlett’s
post hoc test using IBM SPSS (version 20, IBM
Corporation, Armonk, New York, USA). The
Bartlett’s test was used to test the homogeneity of
variance across groups. Graphs were produced
using GraphPad PRISM 6.0. Statistical significance
was set at p < 0.05.

3 Results
3.1 Impact of vmPFC and LHb DBS on FST
performances
Animals treated with bilateral high-frequency
DBS showed a significant decrease in the
immobility time [one-way ANOVA; F = 7.556, p =
0.023; Fig. 2(a)]. Post hoc comparisons revealed
that LHb DBS induced a 56.71% decrease of the
immobility time compared with that of control
animals (p = 0.015). Similarly, a 63.80% shorter
immobility time was observed after vmPFC
stimulation (p = 0.009). Additionally, bilateral
high-frequency DBS of the LHb and vmPFC
increased the climbing time of animals [one-way
ANOVA; F = 24.71, p < 0.0001; Fig. 2(b)]. Moreover,
the swimming time showed no significant

Fig. 1 Schematic of coronal sections depicting implantation sites. (a) vmPFC at +3.0mm from rostral to bregma. (b) LHb at
−3.48, −3.60, −3.84 and −4.20mm from rostral to bregma.

Journal of Neurorestoratology

46

Fig. 2 Antidepressant-like behavioral outcomes of vmPFC

Fig. 3 Anxiety-like behavioral outcomes of vmPFC and

and LHb DBS. Bilateral high-frequency DBS showed a

LHb DBS. Bilateral high-frequency DBS showed a significant

significant decrease in immobility time (a) and a significant

decrease in center distance (a) and center time (b) in the OFT.

increase in climbing time (b) in the FST. There was no

There was no difference in the total distance in the OFT (d).

difference in the time of swimming in the FST (c). Control

Control group, n = 12; LHb DBS group, n = 12; vmPFC DBS

group, n = 12; LHb DBS group, n = 12; vmPFC DBS group,

group, n = 10. *, one-way ANOVA, p < 0.05.

n = 10. One-way ANOVA, *, p < 0.05; ***, p < 0.001. Post hoc
comparisons, #, p < 0.05; ##, p < 0.01.

difference among the three groups [one-way
ANOVA; F = 0.53, p = 0.77; Fig. 2(c)]. These results
suggested that bilateral high-frequency DBS of
the LHb or the vmPFC had similar antidepressant
effects.
3.2 Impact of vmPFC and LHb DBS on OFT
performances
Bilateral high-frequency DBS of the vmPFC
and LHb induced significant differences in the
distance [one-way ANOVA; F = 8.78, p = 0.013;
Fig. 3(a)] and time spent [one-way ANOVA;
F = 6.07, p = 0.048; Fig. 3(b)] in the central area.
Post hoc comparisons revealed that the distance
and time spent in the center were increased after
LHb DBS compared with those of vmPFC DBS
rats (t = 2.63, p < 0.05), whereas there was no
difference between rats receiving LHb or vmPFC
DBS and control animals. Moreover, there was no
difference in the total distance traveled among
the three groups [one-way ANOVA; F = 4.46, p =
0.11; Fig. 3(c)]. The example trajectory diagrams
of different group rats in the OFT were showed
in Fig.4. These results suggested that LHb and

vmPFC DBS did not affect the rat motor activity,
and bilateral high-frequency LHb DBS seemed
to be more effective in reducing anxiety-like
behaviors.

4 Discussion
The bilateral high-frequency LHb and vmPFC
DBS induced a decrease of the immobility time
in the FST, suggesting that DBS of both regions
was similarly effective to generate antidepressant
effects. However, high-frequency DBS of the LHb
only provoked an increase of the time spent and
number of entries in the center area in the OFT,
indicating that LHb DBS might be more effective
in reducing anxiety-like behaviors.
The LHb was identified as a potential target
of DBS in TRD based on its location, as it is
a link between the forebrain and brainstem
monoaminergic nuclei in animals [11]. Moreover,
the pathogenesis of depression described in
detail by Yang et al. involves an increase in the
number of burst-firing neurons in the LHb [21].
The SCG was identified as a potential target of
DBS for TRD based on the increase activity in SCG
of depressive humans observed by Mayberg
Journal of Neurorestoratology
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Fig. 4 Example trajectory diagrams of different group rats in the OFT.

et al. [22]. DBS of both targets improves the

efficacy and side effects of LHb and SCG DBS

depressive symptoms in participants with TRD

in TRD. Our preclinical animal study provides

[3–8, 23–25]. However, DBS of neither of them

information potentially relevant for the clinical

was proven effective in randomized, controlled

efficacy of DBS of these two important targets

clinical studies [6]. The preclinical studies also

in TRD.

showed the antidepressant effects of LHb and

This study had several limitations. First, it

vmPFC DBS in different animal models of

assessed the antidepressive and antianxiety

depression [14, 26–28]. Moreover, both LHb and

effects of DBS in an acute animal model. Second,

vmPFC DBS affect the monoaminergic systems,

the different effects of LHb and vmPFC DBS

including the serotonergic, noradrenergic, and

on anxiety levels remain unexplained, possibly

dopaminergic systems [11, 29–32]. Our behavioral

because the anxiety levels might not have been

data were consistent with the absence of target

adequately measured using the OFT alone.

specificity for DBS antidepressant effects in
humans and animals.
Depression, especially major depression, has
often comorbidities, anxiety being the most
common [33]. Treatment with SCG DBS of more
than 100 patients with TRD demonstrated that a
small number of patients presented increased
anxiety levels [6, 34]. Here, albeit not statistically
significant, there was a trend toward an increased
anxiety in animals receiving vmPFC DBS compared with that of the control group. This was
similar to the clinical observations. Moreover,
there was a significant difference between the

5 Conclusions
Our primary findings showed no target specificity
of bilateral high-frequency LHb and vmPFC
DBS for the antidepressant effects. However,
compared to vmPFC DBS, LHb DBS might be
more effective in reducing anxiety-like behaviors.
The results might constitute a preliminary
preclinical reference for high-frequency DBS of
the SCG and LHb in TRD.

Ethical approval

vmPFC DBS and LHb DBS groups. Although

This study protocol was reviewed and approved

there is a gap between animal and patient studies,

by Animal Use Committee of Peking University

there was no comparative clinical studies on the

Health Science Center (Approval No. LA201713).

Journal of Neurorestoratology

48

Conflict of interests
The authors declare that there is no conflict of

[2]

interests.

Funding

[3]

This work was supported by the National Key
Technologies Research and Development Program

[4]

of China (Grant No. 2019YFC0118502), the
Tsinghua University Initiative Scientific Research
Program (Grant No. 20193080065), the Shenzhen
International Cooperative Research Project

[5]

(Grant No. GJHZ20180930110402104), the National
Natural Science Foundation of China (Grant No.
62071274), the Youth Program of National Natural

[6]

Science Foundation of China (Grant No. 81901345),
and the Chinese Sleep Research Society Hansoh
Project (No. 2019HSB02).
[7]

Authors’ contribution
All authors contributed to the study. Material

[8]

preparation, data collection and analysis were
performed by Fan TT, Zhang YQ, Yi M, Liu NZ,
Hu CH. The first draft of the manuscript was

[9]

written by Wang ZY, and all authors commented
on previous versions of the manuscript. Wang ZY
and Luo L were responsible for the conception,
design and funding of the study and approved

[10]

the final manuscript version.
[11]

Data availability
Available upon request.

[12]

References
[1] Dandekar MP, Fenoy AJ, Carvalho AF, et al. Deep
brain stimulation for treatment-resistant depression: an
integrative review of preclinical and clinical findings

[13]

and translational implications. Mol Psychiatry 2018,
23(5): 1094–1112.
Hitti FL, Yang AI, Cristancho MA, et al. Deep
brain stimulation is effective for treatment-resistant
depression: a meta-analysis and meta-regression. J
Clin Med 2020, 9(9): E2796.
Mayberg HS, Lozano AM, Voon V, et al. Deep brain
stimulation for treatment-resistant depression. Neuron
2005, 45(5): 651–660.
Sartorius A, Kiening KL, Kirsch P, et al. Remission
of major depression under deep brain stimulation of
the lateral habenula in a therapy-refractory patient.
Biol Psychiatry 2010, 67(2): e9–e11.
Holtzheimer PE, Kelley ME, Gross RE, et al.
Subcallosal cingulate deep brain stimulation for
treatment-resistant unipolar and bipolar depression.
Arch Gen Psychiatry 2012, 69(2): 150–158.
Holtzheimer PE, Husain MM, Lisanby SH, et al.
Subcallosal cingulate deep brain stimulation for
treatment-resistant depression: a multisite, randomised,
sham-controlled trial. Lancet Psychiatry 2017, 4(11):
839–849.
Zhang CC, Kim SG, Li DY, et al. Habenula deep brain
stimulation for refractory bipolar disorder. Brain
Stimul 2019, 12(5): 1298–1300.
Wang ZY, Cai XD, Qiu RR, et al. Case report: lateral
habenula deep brain stimulation for treatment-resistant
depression. Front Psychiatry 2021, 11: 616501.
Torres-Sanchez S, Perez-Caballero L, Berrocoso E.
Cellular and molecular mechanisms triggered by Deep
Brain Stimulation in depression: a preclinical and
clinical approach. Prog Neuropsychopharmacol Biol
Psychiatry 2017, 73: 1–10.
Harro J. Animal models of depression: pros and cons.
Cell Tissue Res 2019, 377(1): 5–20.
Matsumoto M, Hikosaka O. Lateral habenula as a
source of negative reward signals in dopamine neurons.
Nature 2007, 447(7148): 1111–1115.
He NY, Sethi SK, Zhang CC, et al. Visualizing the
lateral habenula using susceptibility weighted imaging
and quantitative susceptibility mapping. Magn Reson
Imaging 2020, 65: 55–61.
Hamani C, Diwan M, Macedo CE, et al. Antidepressantlike effects of medial prefrontal cortex deep brain
stimulation in rats. Biol Psychiatry 2010, 67(2): 117–124.
Journal of Neurorestoratology

Journal of Neurorestoratology

[14] Hamani C, Machado DC, Hipólide DC, et al. Deep
brain stimulation reverses anhedonic-like behavior in
a chronic model of depression: role of serotonin and
brain derived neurotrophic factor. Biol Psychiatry
2012, 71(1): 30–35.
[15] Hamani C, Amorim BO, Wheeler AL, et al. Deep brain
stimulation in rats: different targets induce similar
antidepressant-like effects but influence different
circuits. Neurobiol Dis 2014, 71: 205–214.
[16] Tchenio A, Lecca S, Valentinova K, et al. Limiting
habenular hyperactivity ameliorates maternal separationdriven depressive-like symptoms. Nat Commun 2017,
8(1): 1135.
[17] Weersing VR, Gonzalez A, Campo JV, et al. Brief
behavioral therapy for pediatric anxiety and depression:
piloting an integrated treatment approach. Cogn Behav
Pract 2008, 15(2): 126–139.
[18] Sørensen MJ, Nissen JB, Mors O, et al. Age and
gender differences in depressive symptomatology and
comorbidity: an incident sample of psychiatrically
admitted children. J Affect Disord 2005, 84(1): 85–91.
[19] Yang Y, Cui YH, Sang KN, et al. Ketamine blocks
bursting in the lateral habenula to rapidly relieve
depression. Nature 2018, 554(7692): 317–322.
[20] Hamani C, Diwan M, Isabella S, et al. Effects of
different stimulation parameters on the antidepressantlike response of medial prefrontal cortex deep brain
stimulation in rats. J Psychiatr Res 2010, 44(11):
683–687.
[21] Li B, Piriz J, Mirrione M, et al. Synaptic potentiation
onto habenula neurons in the learned helplessness
model of depression. Nature 2011, 470(7335): 535–539.
[22] Mayberg HS. Targeted electrode-based modulation
of neural circuits for depression. J Clin Invest 2009,
119(4): 717–725.
[23] McInerney SJ, McNeely HE, Geraci J, et al. Neurocognitive predictors of response in treatment resistant
depression to subcallosal cingulate gyrus deep brain
stimulation. Front Hum Neurosci 2017, 11: 74.
[24] Merkl A, Aust S, Schneider GH, et al. Deep brain
stimulation of the subcallosal cingulate gyrus in patients
with treatment-resistant depression: a double-blinded
randomized controlled study and long-term follow-up
in eight patients. J Affect Disord 2018, 227: 521–529.

49
[25] Zhang CC, Zhang YY, Luo HC, et al. Bilateral
Habenula deep brain stimulation for treatment-resistant
depression: clinical findings and electrophysiological
features. Transl Psychiatry 2022, 12(1): 52.
[26] Lim LW, Prickaerts J, Huguet G, et al. Electrical
stimulation alleviates depressive-like behaviors of rats:
investigation of brain targets and potential mechanisms.
Transl Psychiatry 2015, 5: e535.
[27] Jiménez-Sánchez L, Castañé A, Pérez-Caballero L,
et al. Activation of AMPA receptors mediates the
antidepressant action of deep brain stimulation of
the infralimbic prefrontal cortex. Cereb Cortex 2016,
26(6): 2778–2789.
[28] Kim Y, Morath B, Hu CL, et al. Antidepressant actions
of lateral habenula deep brain stimulation differentially
correlate with CaMKII/GSK3/AMPK signaling locally
and in the infralimbic cortex. Behav Brain Res 2016,
306: 170–177.
[29] Kale´n P, Strecker RE, Rosengren E, et al. Regulation
of striatal serotonin release by the lateral habenuladorsal raphe pathway in the rat as demonstrated by in
vivo microdialysis: role of excitatory amino acids and
GABA. Brain Res 1989, 492(1/2): 187–202.
[30] Meng HM, Wang YN, Huang M, et al. Chronic deep
brain stimulation of the lateral habenula nucleus in a rat
model of depression. Brain Res 2011, 1422: 32–38.
[31] Torres-Sanchez S, Perez-Caballero L, Mico JA, et al.
Effect of deep brain stimulation of the ventromedial
prefrontal cortex on the noradrenergic system in rats.
Brain Stimul 2018, 11(1): 222–230.
[32] Veerakumar A, Challis C, Gupta P, et al.
Antidepressant-like effects of cortical deep brain
stimulation coincide with pro-neuroplastic adaptations
of serotonin systems. Biol Psychiatry 2014, 76(3):
203–212.
[33] Garber J, Brunwasser SM, Zerr AA, et al. Treatment
and prevention of depression and anxiety in youth: test
of cross-over effects. Depress Anxiety 2016, 33(10):
939–959.
[34] Zhou C, Zhang H, Qin Y, et al. A systematic review and
meta-analysis of deep brain stimulation in treatmentresistant depression. Prog Neuropsychopharmacol
Biol Psychiatry 2018, 82: 224–232.

50

Journal of Neurorestoratology

Tengteng Fan received his M.D. degree from the Peking University the Sixth
Hospital, China (2017). He is now a doctor on psychiatry and mental health in the
Peking University the Sixth Hospital (2017–), China. His current research interests
focus on the clinical treatment of depression, insomnia disorder and cognitive
impairment. E-mail: fantengteng@bjmu.edu.cn

Yuqi Zhang received her B.M. degree from the Department of Basic Medical
Sciences in Peking University in July 2019. Now she is a Ph.D. candidate in
Peking University. Her research focuses on neural mechanism of depression.
E-mail: 1410305130@pku.edu.cn

Zhiyan Wang received her Ph.D. degree from the Institute of Neuroscience, Peking
University, China (2017). She got her postdoctoral training in Tsinghua University,
China (2018–2022). She has published many papers on journals including Brain
Struct & Funct and Neurosci Bull. Her current research interests focus on using
neuromodulation techniques to treat mental disorders. E-mail: wzyann@126.com

Ming Yi received his Bachelor‘s degree in Peking University Health Science Center,
and Ph.D. degree in John O’Keefe (2014 Nobel laureate) group in the Department of
Anatomy and Developmental Biology of University College London. He is currently
a principal investigator and the leader of the Laboratory for Cognitive Neuroscience
in Neuroscience Research Institute of Peking University. He has published many
high-quality papers on journals including Sci Adv and Cell Rep. His current research
interests focus on precise manipulation and functional reconstruction of the memory system. E-mail:
mingyi@hsc.pku.edu.cn

Naizheng Liu received his B.M. degree from the Basic Medical Sciences in Peking
University in July 2021. Now he is a Ph.D. candidate in Peking University. His
research focuses on the mechanism of memory impairment after fear conditioning
during post-traumatic stress disorder. E-mail: 1610305219@pku.edu.cn

Journal of Neurorestoratology

Journal of Neurorestoratology

51

Chunhua Hu received his Ph.D. degree from the Department of Computer Science &
Technology in Tsinghua University in July 2004. He is now an associate professor of
Aerospace Engineering in Tsinghua University. His current research interests focus on
the active implantable medical devices. E-mail: huchunhua@tsinghua.edu.cn

Lei Luo received her M.S. degree from the Peking University in September 2008.
Now she is a supervisor nurse in Peking University the Sixth Hospital. Her research
focuses on the health care for mental disorders, including depression, substance
abuse and dependence. E-mail: LUOLEI626922@163.com

